Viewing Study NCT01294293


Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2025-12-27 @ 2:11 AM
Study NCT ID: NCT01294293
Status: COMPLETED
Last Update Posted: 2014-12-25
First Post: 2011-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Sponsor: Gynecologic Oncology Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module